Data compiled by Redley Lamar · ChainSifter Intelligence
6Suppliers
6Customers
3Debt Items
7Related Chains
Source-Backed Evidence Depth
ABVC BioPharma, Inc. (ABVC) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
16Total relationships
1Distinct source URLs
10High confidence
0.795Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
ABVC BioPharma, Inc. Suppliers
Ticker
Name
Confidence
Evidence
AIBTL-BIOPHARMA-INC
AIBTL-BIOPHARMA-INC
90%
License Agreement between the Company and AiBtl BioPharma Inc.
BIOFIRST-CORPORATION
BIOFIRST-CORPORATION
90%
Definitive License Agreement between BioFirst Corporationand ForSeeCon Eye Corporation
BIOLITE-INC
BIOLITE-INC
90%
Definitive License Agreement between Biolite, Inc. and OncoX BioPharma, Inc.
FORSEECON-EYE-CORPORATION
FORSEECON-EYE-CORPORATION
90%
Definitive License Agreement between the Company and ForSeeCon Eye Corporation
ONCOX-BIOPHARMA-INC
ONCOX-BIOPHARMA-INC
90%
Definitive License Agreement between the Company and OncoX BioPharma, Inc.
RGENE
RGENE
90%
Definitive License Agreement between Rgene and OncoX BioPharma, Inc.
ABVC BioPharma, Inc. Customers
Ticker
Name
Confidence
Evidence
COMPANY-LUCIDAIM-CO-LTD
COMPANY-LUCIDAIM-CO-LTD
62%
In February and December of 2015, BioLite, Inc. entered into a total of three joint venture agreements with BioHopeKing to jointly develop ABV-1501 for Triple Negative Breast Cancer (TNBC), ABV-1504 …
FORSEECON-EYE-CORPORATION
FORSEECON-EYE-CORPORATION
62%
eement upon certain defaults committed by another Shareholder, as set forth in the Agreement. This was a related party transaction. In 2024, the Company recognized fully $150,000 loss in equity metho…
Reciprocal relationship from LCID graph: Reciprocal relationship from ABVC graph: In February and December of 2015, BioLite, Inc. entered into a total of three joint venture agreements with BioHopeKi…
ONCOX-BIOPHARMA-INC
ONCOX-BIOPHARMA-INC
62%
e candidates from large research institutes and universities in both the U.S. and Taiwan. Through an assertive product development approach, we expect that we will build a substantial portfolio of On…
ONCOX-BIOPPHARMA-INC
ONCOX-BIOPPHARMA-INC
62%
e candidates from large research institutes and universities in both the U.S. and Taiwan. Through an assertive product development approach, we expect that we will build a substantial portfolio of On…
TAIWAN-CENTRAL-DEPOSIT-INSURANCE-CORPORATION
TAIWAN-CENTRAL-DEPOSIT-INSURANCE-CORPORATION
62%
y be in excess of the limit of $ 95,400 (NTD 3.0 million) covered by Taiwan Central Deposit Insurance Corporation, and the limit of $ 250,000 covered by the U.S. Federal Deposit Insurance Corporation…
ABVC BioPharma, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
ABVC-DEBT-7446
Warrants outstanding: 500000
90%
xbrl warrant detail from xbrl 2025-12-31.
ABVC-DEBT-7447
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
ABVC-DEBT
Debt stack $3.5M
90%
Market cache reports total debt of $3.5M.
ABVC BioPharma, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for ABVC BioPharma, Inc..
ABVC BioPharma, Inc. Ownership
Holder
Name
Confidence
Evidence
ABVC-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 15 tracked holders.
ABVC BioPharma, Inc. Extended Supply Chain Network
